Evidence map›Paper›PMID 42585351›Full record

ArticleJournal of Alzheimer's disease : JAD2026

Risk factors and cognitive domain markers of progression in subjective cognitive decline.

Omonigho M Bubu, Alfred K Mbah, Mark A Bernard, Anthony Briggs, Arline Faustin, Lindsey Gurin, Julia A Rao, Sakina Ouedraogo Tall, Ricardo S Osorio, Arjun V Masurkar

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Omonigho M BubuNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.ORCID 0000-0001-7438-2628
Alfred K MbahCytel Inc,, Cambridge, MA, USA.
Mark A BernardNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Anthony BriggsNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Arline FaustinNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Lindsey GurinNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Julia A RaoNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Sakina Ouedraogo TallNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Ricardo S OsorioNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.
Arjun V MasurkarNYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, NY, USA.

Funding

PSYCHOSOCIAL COREP30AG008051 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WISNIEWSKI, THOMAS M · 1990 to 2019
$36.1M
Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Mary Sherman Mittelman · 2020 to 2026
$28.4M
Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-AmericansR01AG082278 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OMONIGHO A MICHAEL Bubu · 2023 to 2026
$6.9M
Slow wave sleep (SWS) and the effect of African ancestry on amyloid burden, a longitudinal studyR01AG056531 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JEAN-LOUIS, GIRARDIN, OSORIO, RICARDO S · 2018 to 2022
$6.7M
Research Education CoreP30AG059303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ADAM M BRICKMAN, Jennifer Jaie Manly · 2018 to 2026
$6.0M
Sleep Aging and Risk for Alzheimer's disease-Resubmission-1R01AG056031 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OSORIO, RICARDO S · 2018 to 2022
$4.4M
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacksRF1AG083975 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI OMONIGHO A MICHAEL Bubu, Korey Kam · 2023 to 2026
$4.2M
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's DiseaseR01AG072644 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DING, YU-SHIN, OSORIO, RICARDO S · 2021 to 2024
$3.3M
Differential impact of Alzheimer disease on neuronal subpopulations in dorsal hippocampal CA1RF1AG072507 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MASURKAR, ARJUN VIJAY · 2021 to 2021
$1.9M
The mediating role of Slow Wave Sleep and Vascular Risk Factors on Alzheimer Disease related disparity between African-Americans and non-Hispanic WhitesK23AG068534 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUBU, OMONIGHO A MICHAEL · 2021 to 2025
$958k
Alterations in Ventral Hippocampal CA1 Processing as a Mechanism for Anxiety in Alzheimer’s DiseaseR21AG070880 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MASURKAR, ARJUN VIJAY · 2021 to 2022
$466k
NIA NIH HHS K23 AG068534NIA NIH HHS L30 AG064670NIA NIH HHS P30 AG008051NIA NIH HHS P30 AG059303NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG056031NIA NIH HHS R01 AG056531NIA NIH HHS R01 AG072644NIA NIH HHS R01 AG082278NIA NIH HHS R21 AG070880NIA NIH HHS RF1 AG072507NIA NIH HHS RF1 AG083975
6 · The paper itself

Abstract

BackgroundSubjective cognitive decline (SCD) is increasingly recognized in some cases as an early clinical stage in the Alzheimer's disease continuum, yet the factors that predict which individuals will progress to objective impairment remain poorly understood.ObjectiveWe evaluated risk factor differences and cognitive domain markers associated with progression in participants with subjective cognitive decline (SCD) at baseline from the NYU Alzheimer's Disease Research Center.MethodsWe included SCD non-decliners (n = 27), who remained stable, and decliners (n = 24), who progressed to mild cognitive impairment or worse, between the second to sixth yearly follow-up visits. Adjusted mixed-effects models examined group differences and associations between demographic,

Indexed as

Cognitive DysfunctionAgedBiomarkersDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsRisk FactorsBiomarkersAlzheimer's diseasecognitionmemoryolder adultssubjective cognitive decline

Identifiers

PMID42585351
PMCPMC13501928

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.